Mixed day for COVID VACCINE STOCKS as the overall market's brief winning streak came to an end. 11 of these stocks were up, 12 down, with two unchanged. Novavax (NVAX) was the winner today, up 6.25%. Zack's put out a couple articles on NVAX today:
NVAX is up 1200% this year. Not bad.
NanoViricides (NNVC) dropped 5.36% which was the weakest performer in the group.
Speaking of stocks with a down day, Chembio Diagnotics (CEMI) lost an FDA approval for its serology COVID test.
As COVID VACCINE investors, we need to ask ourselves if we are ready for that inevitable day when this happens to one or more or all of our holdings. Yikes.
No comments:
Post a Comment